ad-block

Advertising seems to be blocked by your browser.

The ads help us provide this software and web site to you for free.

Please support our project by allowing our site to show ads.



USBDEVICE - MYLAN GROUP - MYLAN GROUP VENUS Drivers Download


Computer driver update - DriverMax

Device types / USBDEVICE / MYLAN GROUP / MYLAN GROUP VENUS


Driver Date
2013-01-14  
Version
1.2.722.0  
Driver for
Windows 2000 (5.0) 32 bit
Windows XP (5.1) 32 bit
Windows Server 2003 (5.2) 32 bit
Windows Vista (6.0) 32 bit
Windows 7 (6.1) 32 bit
Windows 8 (6.2) 32 bit
Windows 8.1 (6.3) 32 bit
Windows 10 (10.0) 32 bit
Download
Driver Date
2013-01-14  
Version
1.2.722.0  
Driver for
Windows 2000 (5.0) 64 bit
Windows XP (5.1) 64 bit
Windows Server 2003 (5.2) 64 bit
Windows Vista (6.0) 64 bit
Windows 7 (6.1) 64 bit
Windows 8 (6.2) 64 bit
Windows 8.1 (6.3) 64 bit
Windows 10 (10.0) 64 bit
Download



Description extracted from Wikipedia:

NameMylan N.V.
IndustryPharmaceuticals
Key peopleHeather Bresch, CEO
Operating incomedecrease (2018)
Number of employees~35,000 (December 2018)

Mylan N.V. was a global generic and specialty pharmaceuticals company domiciled in the Netherlands, with principal executive offices in Hatfield, Hertfordshire, UK and a "Global Center" in Canonsburg, Pennsylvania, US. In 2007, the company acquired a controlling interest in India-based Matrix Laboratories Limited, a top producer of active pharmaceutical ingredients (APIs) for generic drugs, and the generics business of Germany-based Merck KGaA. Through these acquisitions, the company grew from the third-largest generic and pharmaceuticals company in the United States to the second-largest generic and specialty pharmaceuticals company in the world. The company develops and produces medicines for a wide range of medical disciplines, including oncology, anaphylaxis, antiretrovirals, cardiovascular, respiratory, dermatology, immunology, anesthesia and pain management, infectious disease, gastroenterology, diabetology/endocrinology, and women's healthcare. In July 2019, the company and Pfizer announced that Pfizer would spin off and merge its off-patent medicine division, Upjohn, with Mylan. The merged company now operates under the name of Viatris.